Recommendation ID
CG117/4
Question
Protective effects of Bacille Calmette-Guèrin (BCG):- A case-control study is needed, comparing people who developed active or latent tuberculosis (TB) with those who did not, and comparing the proportions of people in each group who had been vaccinated and the time since vaccination. The aim will be to derive improved estimates of protective efficacy and duration of protection of the BCG vaccine.
Any explanatory notes
(if applicable)
Why this is important:- There is little up-to-date evidence on the duration of Bacille Calmette-Guèrin (BCG) protection in England and Wales across various age ranges and population groups. This information would aid the development of future BCG vaccination policies in these groups.

Source guidance details

Comes from guidance
Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control
Number
CG117
Date issued
March 2011

Other details

Is this a recommendation for the use of a technology only in the context of research? N/A  
Is it a recommendation that suggests collection of data or the establishment of a register?   N/A